文献速递糖尿病

德国糖尿病合并抑郁患者的医疗利用与费用:DiaDec横断面研究

Health Care Use and Costs in Individuals With Diabetes With and Without Comorbid Depression in Germany: Results of the Cross-sectional DiaDec Study.
PubMed 文献 · Diabetes Care · 2020-12-14

该研究基于2013年德国法定健康保险横断面调查数据(n=1,634),个体链接保险数据,比较糖尿病无抑郁与合并抑郁(症状或诊断)患者的医疗利用与费用。结果显示合并抑郁者年均总费用更高(5,629欧元 vs 3,252欧元),校正后费用比1.25,超额费用与合并症高度相关,心理健康服务费用总体较低。

要点

  • 糖尿病合并抑郁者年均总费用5,629欧元,无抑郁者3,252欧元,校正费用比1.25。
  • 超额费用与合并症高度相关,心理健康服务费用绝对值较低。
  • 抑郁症状或诊断均与总费用升高相关,需关注共病管理。

核心结论

  • 糖尿病合并抑郁(症状或诊断)者总医疗费用显著高于无抑郁者,校正费用比为1.25(95%CI 1.14-1.36)。
  • 超额费用与合并症高度相关,心理健康服务费用相对较低。

研究设计与样本

  • 基于2013年德国法定健康保险随机抽样成员的横断面调查(n=1,634),个体链接保险数据覆盖调查前后各四个季度。
  • 抑郁症状采用患者健康问卷-9(PHQ-9)评估,抑郁诊断取自保险数据。
  • 采用回归分析计算校正社会人口学/社会经济因素与合并症后的费用比(CR)。

主要发现

  • 合并抑郁者年均总医疗费用为5,629欧元(95%CI 4,987-6,407),无抑郁者为3,252欧元(95%CI 2,976-3,675)。
  • 校正后费用比(CR)为1.25(95%CI 1.14-1.36)。
  • 无抑郁者心理治疗费用年均2欧元、抗抑郁药费用4欧元;合并抑郁者分别为111欧元和76欧元。

临床怎么用

  • 在糖尿病管理中应识别抑郁症状或诊断,其与医疗费用升高相关。
  • 关注合并症管理可能有助于控制超额费用。
  • 心理健康服务费用绝对值较低,提示服务利用可能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Increased health care use and costs have been reported in individuals with diabetes with comorbid depression. Knowledge regarding cost differences between individuals with diabetes alone and those with diabetes and diagnosed/undiagnosed depression is, however, scarce. We therefore compared use and costs for patients with diabetes and no depression and patients with diabetes and documented depression diagnosis or self-reported depression symptoms for several cost components, including mental health care costs. RESEARCH DESIGN AND METHODS: Data from a 2013 cross-sectional survey of randomly sampled members of a nationwide German statutory health insurance (SHI) provider with diabetes (n = 1,634) were linked individually with SHI data covering four quarters before and after the survey. Self-reported depression symptoms were assessed with the Patient Health Questionnaire-9, with depression diagnosis taken from SHI data. We analyzed health care use and costs, using regression analysis to calculate cost ratios (CRs) with adjustment for sociodemographic/socioeconomic factors and comorbidities for two groups: 1) those with no symptoms and no diagnosis and 2) those with symptoms or diagnosis. In our explorative subanalysis we analyzed subgroups with either symptoms or diagnosis separately. RESULTS: Annual mean total health care costs were higher for patients with comorbid depression (EUR 5,629 [95% CI 4,987-6,407]) than without (EUR 3,252 [2,976-3,675], the CR being 1.25 [1.14-1.36]). Regression analysis showed that excess costs were highly associated with comorbidities. Mental health care costs were very low for patients without depression (psychotherapy EUR 2; antidepressants EUR 4) and still relatively low for those with depression (psychotherapy EUR 111; antidepressants EUR 76). CONCLUSIONS: Costs were significantly higher when comorbid depression was present either as symptoms or diagnosed. Excess costs for mental health services were rather low.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Brüne M, Linnenkamp U, Andrich S, et al. Health Care Use and Costs in Individuals With Diabetes With and Without Comorbid Depression in Germany: Results of the Cross-sectional DiaDec Study. Diabetes Care. 2020. PMID: 33318124. doi:10.2337/dc19-2487

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。